In a remarkable demonstration of the potential nested within the life sciences sector, David Dean Halbert, founder of Caris Life Sciences, has successfully transformed a fledgling biotech venture into a formidable player in the global market. Halbert, who acquired the Molecular Profiling Institute in 2008 with an ambitious vision of developing a blood-based platform for […]